IDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filings (opens in new tab)
IDBS and Alchemi partnered to connect AI agents with data in the IDBS Polar platform, creating a governed data foundation that enables reliable, compliant agentic AI use throughout drug development. The post appeared first on .
Read the original article